Recent Updates
Recently added Catalysts
ENOV Positive Sentiment Score: 70/100

Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

Key Takeaway: Enovis Corporation announced it will host an investor conference call on February 26, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results. The company plans to issue an earnings press release earlier that same morning. Investors can access the call via a live webcast and a replay will be available on their website later in the day. Enovis emphasizes its innovation-driven approach, focusing on improvements in patient outcomes and orthopedic solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is hosting a conference call to discuss financial results, indicating transparency.
  • The company is focused on innovation and improvement, suggesting potential for growth.
  • Their dedication to clinically differentiated solutions reflects a commitment to patient outcomes.

Full Press Release Details

Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2024 financial results on Wednesday, February 26th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call as well as a webcast can be accessed from the "Investors" section of Enovis' website at www.enovis.com.
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Vice President, Investor Relations

Frequently Asked Questions

When is Enovis' investor conference call?

Enovis' investor conference call is scheduled for February 26th, 2025, at 8:30 a.m. ET.

How can I access the live webcast for Enovis' call?

The live webcast can be accessed via a link on Enovis' website under the 'Investors' section.

What number should I call to join the Enovis conference call?

U.S. callers can dial (833) 685-0901 and international callers can call (412) 317-5715.

Where can I find information about Enovis?

Investors can find information on Enovis through their Investor Relations website at ir.enovis.com.

What stock exchange lists Enovis Corporation?

Enovis Corporation is listed on the New York Stock Exchange under the symbol ENOV.

Last updated: Jan 29, 2025